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Abstract. Quantitative medical image computing (radiomics) has been
widely applied to build prediction models from medical images. However,
overfitting is a significant issue in conventional radiomics, where a large
number of radiomic features are directly used to train and test models
that predict genotypes or clinical outcomes. In order to tackle this prob-
lem, we propose an unsupervised learning pipeline composed of an au-
toencoder for representation learning of radiomic features and a Gaussian
mixture model based on minimum message length criterion for cluster-
ing. By incorporating probabilistic modeling, disease heterogeneity has
been taken into account. The performance of the proposed pipeline was
evaluated on an institutional MRI cohort of 108 patients with colorec-
tal cancer liver metastases. Our approach is capable of automatically
selecting the optimal number of clusters and assigns patients into clus-
ters (imaging subtypes) with significantly different survival rates. Our
method outperforms other unsupervised clustering methods that have
been used for radiomics analysis and has comparable performance to a
state-of-the-art imaging biomarker.
Keywords: MRI· Radiomics · Unsupervised clustering · Liver metas-
tases · Probabilistic generative modeling
1 Introduction
Quantitative medical image computing, known as radiomics, has been an emerg-
ing field in medical image analysis. The goal of radiomics is to extract hun-
dreds of features that are mathematical summarizations of the volume-of-interest
(VOI) from computed tomography (CT), magnetic resonance imaging (MRI) or
positron emission tomography (PET), for the purpose of disease characteriza-
tion and patient stratification. Imaging biomarkers built on radiomic features
have demonstrated great performance in predicting patients outcome [1, 5, 7].
However, there are two critical issues in radiomics analysis.
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First, there is always the possibility of overfitting. Building statistically pow-
erful models at medically meaningful effect sizes using hundreds of radiomic
features would at least require thousands of samples [9], while such datasets
are rarely available for research in medical settings. Even with generalization
techniques such as feature reduction and cross-validation, overfitting remains a
primary concern.
Second, conventional radiomics analysis does not necessarily consider the
heterogeneity of the disease of interest. Breast cancer imaging subtypes identified
using a radiomics approach are distinct from established breast cancer molecular
and pathological subtypes [13]. This suggests that tumors in different subtypes or
genotypes may have similar appearances. However, radiomic models are usually
trained with either linear or deterministic models such as logistic regression or
support vector machines for subtype prediction. These approaches are not ideal
for the modeling of overlapping distributions.
Unsupervised clustering can be leveraged to alleviate these problems. Con-
sensus clustering (CC), for example, has been used with radiomic features ex-
tracted from the tumor and surrounding parenchyma to define imaging subtypes
in breast cancer [8, 13]. However, it is difficult to glean further insights of the
imaging subtypes through clustering without additional analyses, and often non-
trivial to select the optimal number of clusters.
In this paper, we alleviated the issues of overfitting and non-distinct fea-
ture distributions using a radiomics pipeline that identifies imaging subtypes
based on radiomic features using a probabilistic generative model with mini-
mum supervision. We made use of an autoencoder to reduce the dimensions of
our radiomic features and find representations with minimal correlations. We
incorporated a Gaussian mixture model (GMM) with minimum message length
criterion (MML) to cluster patient MRIs into imaging subtypes using the learned
representations of features [3]. We compared the performance of other clustering
algorithms with our approach and investigated the clinical value of the defined
imaging subtypes. In addition, we demonstrated that the imaging subtypes de-
rived from our pipeline have comparable prognostic ability to state-of-the-art
clinical and imaging biomarkers.
2 Method
The workflow of our unsupervised clustering radiomics analysis includes five
steps. (Fig. 1). First, quantitative imaging features are extracted from MRI
scans. Then an autoencoder is applied to learn feature representations for the
purpose of dimension reduction. Next, the learned representations from the la-
tent space are clustered using a GMM. Finally, the significance and clinical value
of the learned imaging subtypes (clusters) are evaluated. Clinical outcome is held
out during model training and only used in evaluation stage.
Radiomic Feature Extraction The first step of our pipeline was MRI tumour
lesion segmentation and radiomic features extraction. The MRIs were resampled
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Fig. 1. Workflow of the proposed unsupervised radiomics pipeline
to isotropic spacing [3,3,3] using B-spline transformation. A Z-score transforma-
tion was applied to normalize the resampled images and rescale their intensities
to range from 0 to 100. Outliers with extreme intensity values were capped in
normalization. Image discretization was performed using a bin width of 5 to
simplify computation. Finally, 100 features from three categories describing the
characteristics (intensity, shape and texture) of the volume of interest, e.g. tu-
mour lesions, were extracted using pyradiomics [11].
Quantile Normalization We observed that radiomic features extracted from
medical images frequently included outliers, i.e. samples with extreme feature
values. However, in order to be able to reconstruct features from very few latent
features in autoencoders, extreme values should be avoided. Experimentally we
found that Z-normalization and capping did not work well for this problem.
Hence, we used a quantile normalization approach with thresholds designed for
radiomic features. We transform feature quantiles: 0-5% (min), 5-25%, 25%-
50%, 50%-75%, 75%-95%, 95%-100% (max) to floats: 0, 1/6, 2/6, 3/6, 4/6, 5/6,
1, respectively. The quantile thresholds were empirically determined based on
experiments.
Fig. 2. Network architecture of the autoencoder with fully-connected layers used for
feature representation learning. The numbers in the blocks denote number of hidden
units in each layer.
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Feature Representation Learning (with autoencoder) With the trans-
formed radiomic features, we leveraged an autoencoder to learn feature repre-
sentations i.e. features in low dimensional latent space that best summarize the
data. The input for the autoencoder was the 100-element radiomic feature vector
previously mentioned (Fig. 2). There were five layers for both the encoder and
the decoder. A relatively deep structure compared to the size of input was used
to add non-linearity. The autoencoder was blinded to all clinical information to
prevent overfitting. All layers were fully connected with SELU activation [6]. We
chose three as the number of latent features because there were three categories
of radiomic features. The latent features were used as the input for subsequent
unsupervised clustering.
Unsupervised Clustering (with GMM-MML) Given the known extant
of heterogeneity in cancer, imaging phenotypes of tumors with different geno-
types/subtypes cannot be expected to be discrete. This motivated the choice of
a probabilistic model instead of a deterministic one for tumor image clustering
across known molecular and pathological categories. Therefore, we used a GMM
for the unsupervised discovery of imaging subtypes.
Gaussian mixtures are weighted linear combinations of c-component Gaus-
sians that are used to model a probability density. The optimum number of
components c and parameters θ are estimated using minimum message length
criterion (MML) [3]. The idea of MML is to simplify estimation of GMM pa-
rameters by minimization of encoding length. Consider a dataset Y which is
generated from a probabilistic distribution p(Y|θ), the message length required
to encode and transmit Y is:
L(θ,Y) = L(θ) + L(Y|θ)) (1)
where θ is the prior and L is the encoding message length.
Then θ and c can be simultaneously estimated using the following equation:
θˆ = argmin
θ
{− log p(θ)− log p(Y|θ) + 1
2
log |I(θ)|+ c
2
(1 + log
1
12
)} (2)
where |I(θ)| is the determinant of the expected Fisher information matrix [3].
3 Experiments and Results
3.1 Experimental Design
Data Description The dataset we used is an institutional retrospective cohort
of 108 patients with colorectal cancer liver metastases (CRCLM). The num-
ber of slices for each volume is between 57 and 170 (mean=100). Institutional
Review Board approved the study and waived informed consent. Gadobutrol-
enhanced liver MRIs, specifically 10-minute-delayed T1 MRIs were acquired after
chemotherapy and prior to hepatic resection, with 1.5/3T MR systems. Tumor
segmentation was performed by a single reader with 6 years of experience. The
reader was blinded to all clinical information expect patient history of CRCLM.
Patient mortality right-censored at three years were available.
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Implementation Details Radiomic feature extraction was implemented using
packages pyradiomics (v2.0.0) [11], numpy (v1.14.3) and SimpleITK (v1.1.0) in
Python (v2.7.15).
An autoencoder was trained with Keras on a NVIDIA TITAN Xp Graphics
Card (with 12G memory). The loss function was set to binary cross entropy loss.
We used adam optimization with a mini-batch size of 64. Default parameters
were used, specifically initial learning rate of 0.001, decay rates of 0.9 and 0.999.
The model was trained for 400 epochs.
GMM with MML was implemented using Python package gmm-mml (v0.11).
Initial number of clusters k max was set to 25. Maximum iteration of 100 and
convergence threshold of 10−5 was used.
Evaluation Metrics In radiomic subtype classification tasks, there is no “ground
truth”. Thus, instead of using normalized mutual information and Rand index,
which are typically used for evaluating the performances of unsupervised clus-
tering methods, we evaluated the clinical value of our imaging clusters according
to their association with patient outcome. Cox proportional hazard models were
built for comparing different unsupervised clustering methods, in terms of con-
cordance index (CI), hazard ratio (HR) and p-value. A cluster number of three
was automatically selected by both GMM-MML and the heuristic algorithms
provided in SIMLR (v1.8.1) [12], so we compared the methods by the maximum
pair-wise HR produced from their clustering results.
Evaluation The resulting clusters from our pipeline and their clinical values
were demonstrated using a kaplan-meier plot and results from a log-rank test.
We also compared our approach with other unsupervised clustering methods
that have been used to cluster radiomic features, including baseline consensus
clustering [8, 13] and state-of-the-art SIMLR [12]. Further, we compared our
approach to validated clinical and imaging biomarkers for prognostic ability [2,4].
Method Concordance index↑ Hazard ratio↑ P value
CC [8] 0.531±0.046 2.90 (0.75-14.45) 0.113
SIMLR [12] 0.582±0.047 3.20 (0.73-13.93) 0.122
AE+GMM+MML 0.623±0.052 3.32 (1.35-8.18) 0.009*
Table 1. Comparison of unsupervised learning algorithms for imaging phenotype clus-
tering. Numbers in parentheses are confidence intervals.“*” denotes significant p value.
3.2 Results
We estimated Gaussian mixtures of latent representations of radiomic features
from liver MRIs using our pipeline. Three Gaussian distributions were learned,
each representing an imaging subtype (Figure 3.a-b). We compared the raw
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radiomic feature distributions of the three tumor subtypes. We found subtype II
tumors to be larger but otherwise very similar to subtype I tumors. In contrast,
tumors in subtype III were drastically different from the other two, mostly with
higher heterogeneity in texture and were more elongated. There are 46, 41 and
21 patients in cluster I-III, respectively. Patients in subtype III had significantly
worse survival rates than patients in the other two subtypes (Figure 3.c).
Fig. 3. Image subtypes defined by our pipeline (a) from left to right, example images
that are representative of cluster I, II and III tumors, respectively. Tumor regions of
interest are marked in red. (b) latent features and the estimated Gaussian mixtures.
The x- and y-axis of each subplot are latent features values (indexed 0-2). (c) 3-year
survival rates for patients assigned to different subtypes.
We compared our approach and other unsupervised clustering algorithms for
defining imaging subtypes (Table 1). Our approach achieved the highest CI and
the only statistically significant HR of 3.32 [1.35-8.18]. Therefore our approach
was uniquely able to produce imaging subtypes predictive of patient survival.
In addition, the estimated GMM components can be used to model theoretical
distributions of CRCLM tumor appearance and be expanded to a validated
training-testing model, while the subtypes defined by SIMLR and consensus
clustering are hard to interpret and cannot be expanded to incorporate new
samples.
We also compared the prognostic ability of our approach to other biomarkers
for CRCLM (Table 2). The Fong score is a clinical risk score based on five inde-
pendent preoperative risk factors built to predict patient prognosis [4]. Target-
tumor-enhancement (TTE) is an imaging biomarker specifically designed for
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stratifying CRCLM patients with late-gadolinium-enhanced MRI [2]. The com-
parison was based on a subset of 99 patients who had all three biomarkers
available. Our approach outperformed the Fong score and had comparable per-
formance to TTE in predicting 3-year survival rates for CRCLM patients.
Method Hazard ratio↑ P value
Fong score [4] 2.28 [0.96-5.42] 0.060
Target tumor enhancement [2] 4.06 [1.73-9.51] 0.001*
AE+GMM+MML 3.98 [1.60-9.89] 0.003*
Table 2. Comparison of our approach with clinical and imaging biomarkers for CR-
CLM. The methods are adjusted for age and sex. Numbers in parentheses are confidence
intervals.“*” denotes significant p value.
4 Discussion and Conclusion
Probabilistic generative modeling for unsupervised clustering can alleviate the
issues of overfitting and overlapping feature distributions in radiomics analysis.
We proposed an unsupervised pipeline composed of an autoencoder and a GMM-
MML for identifying imaging subtypes from radiomic features that achieved clin-
ically meaningful results. Experiments showed that our approach outperformed
other unsupervised algorithms typically used in radiomics by finding imaging
subtypes that were associated with patient survival. We also demonstrated that
our unsupervised model outperformed a clinical prognostic biomarker and had
comparable performance to a state-of-the-art imaging biomarker designed for
this specific tumor type and contrast agent.
Due to the modest sample size, we didn’t perform a train-test split for fea-
ture representation learning and Guassian mixture modeling. However, since the
prediction of patient survival rate was independent of radiomic feature encoding
and clustering, the survival difference between imaging subtypes were not due to
overfitting in this respect. Also, our study was based on manual segmentations
of tumor lesions. In future work, we will apply convolutional neural network
structures which can extract features directly from MRI scans and remove the
need of manual segmentations.
The underlying biological mechanisms of the identified imaging clusters can
be elucidated further using pathway enrichment analysis [10, 13]. Investigations
into targetable recurrent mutational or expressional changes in the subtypes may
also open the way to guided personalized treatments for colorectal cancer liver
metastases patients based on imaging analysis.
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